Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma

Publisher： Karger

E-ISSN： 1421-9662|135|2|113-121

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.2, 2016-0, pp. : 113-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Agents for the Treatment of Primary Plasma-Cell Leukemia: Lights and Shadows

By  

Acta Haematologica, Vol. 135, Iss. 2, 2016-0 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Extramedullary disease in multiple myeloma in the era of novel agents

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 763-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 211-219

Karger

Access to resources Recommend Favorite

New Recurrent Chromosome Alterations in Patients with Multiple Myeloma and Plasma Cell Leukemia

By  

Cytogenetic and Genome Research, Vol. 134, Iss. 4, 2011-07 ,pp. : 249-259

Karger

Access to resources Recommend Favorite

Significantly Better Prognosis for Patients with Primary Plasma Cell Leukemia than for Patients with Secondary Plasma Cell Leukemia

By  

Acta Haematologica, Vol. 118, Iss. 3, 2007-10 ,pp. : 178-182

Karger

Access to resources Recommend Favorite